AAPP supports access to mood stabilizers, including lithium, for the treatment of bipolar disorder. Psychiatric pharmacists are encouraged to use this policy brief to support your own advocacy for this gold-standard treatment.
Advocating for the Evidence: Mood Stabilizers for Bipolar Disorder